InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,954.40
(
-0.17%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.98
(
0.53%
)
Bitcoin
57,360.06
(
-1.51%
)
Post# of 130502
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Solantey

Send PM Follow Ignore
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Solantey

Re: reki127 post# 106866

Sunday, 08/03/2014 11:15:14 AM

Sunday, August 03, 2014 11:15:14 AM

Post# of 130502
In a press release dated December 15, 2102 entitled "Amarantus BioScience Licenses LymPro Alzheimer's Disease Diagnostic Blood Test" the following information was provided by the company:

"LymPro has completed two Phase 1 clinical studies in over 80 patients, showing 98% sensitivity and 96% specificity for Alzheimer's disease diagnosis."

http://www.fiercemedicaldevices.com/press-releases/amarantus-bioscience-licenses-lympro-alzheimers-disease-diagnostic-blood-te

Can someone please explain what happened to this data. I can't find it referenced in the recent A.A.I.C. posters or the C4CT data for LymPro. Were the numbers for real? I was expecting similar numbers at the C4CT Summit.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Start posting your company's news
Only $200 per official company press release!